Valneva(VALN) - 2023 Q1 - Quarterly Report

EXHIBIT 99.1 Valneva to Present on its Chikungunya Vaccine Candidate and Host a Roundtable at the 23rd World Vaccine Congress in Washington D.C. Saint Herblain (France), March 30, 2023 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today it will present on its single-shot chikungunya vaccine candidate, VLA1553, and host a roundtable on Zika vaccines next week at the 23 World Vaccine Congress in Washington, D.C. On April 4, 2023, at 11.40am EDT, Valneva's Chief Medica ...